Webinar | July 17, 2019

Mitigating Risk Through Product Characterization

Source: MilliporeSigma

In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.

  • Characterization of therapeutic antibodies
    • what, why, and when
    • Benefits of early use of PC approaches to understand your product
  • Complexities of monoclonal (mAbs) and their characterization
  • Approaches to characterization of mAb physico-chemical and structural attributes
  • Functional characterization of mAbs
VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: